{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:47:31Z","timestamp":1759333651770},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1365-2133.2010.09758.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T15:37:34Z","timestamp":1268235454000},"page":"1359-1364","source":"Crossref","is-referenced-by-count":8,"title":["High-concentration (20\u2003\u03bcg\u2003g<sup>\u22121<\/sup>\n) tacalcitol ointment in the treatment of facial psoriasis: an 8-week open-label clinical trial"],"prefix":"10.1093","volume":"162","author":[{"given":"J.W.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-W.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-H.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-I.","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF02505274","article-title":"Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice","volume":"288","author":"Sato","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00003495-199754020-00005","article-title":"Tacalcitol","volume":"54","author":"Peters","year":"1997","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-2133.2002.04567.x","article-title":"Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis","volume":"146","author":"Van De Kerkhof","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB4|cit4","first-page":"463","article-title":"Long-term safety and efficacy of high-concentration (20\u2003microg\/g) tacalcitol ointment in psoriasis vulgaris","volume":"12","author":"Miyachi","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB5|cit5","first-page":"553","article-title":"High-concentration (20\u2003mug\/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids","volume":"12","author":"Katayama","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jaad.2008.02.006","article-title":"Classification of facial psoriasis based on the distributions of facial lesions","volume":"58","author":"Woo","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1365-2133.2008.08495.x","article-title":"Method of assessing involved facial areas: rule of fours","volume":"158","author":"Yoon","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2230.1985.tb02550.x","article-title":"Facial psoriasis","volume":"10","author":"Harrison","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-4362.1983.tb02139.x","article-title":"Facial sparing in psoriasis","volume":"22","author":"Bernhard","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0190-9622(03)02793-2","article-title":"Facial psoriasis: comparison of patients with and without facial involvement","volume":"50","author":"Young Park","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1365-2230.1985.tb00615.x","article-title":"Is facial involvement a sign of severe psoriasis?","volume":"10","author":"Bernhard","year":"1985","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB12|cit12","first-page":"169","article-title":"Is facial involvement a sign of severe psoriasis?","volume":"18","author":"Canpolat","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000422371","article-title":"Side effects of topical glucocorticoids","volume":"21","author":"Mills","year":"1993","journal-title":"Curr Probl Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archderm.141.9.1152","article-title":"Pimecrolimus and tacrolimus for the treatment of intertriginous and facial psoriasis: are they effective?","volume":"141","author":"Bigby","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archderm.141.9.1154","article-title":"Proven efficacy of tacrolimus for facial and intertriginous psoriasis","volume":"141","author":"Lebwohl","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","article-title":"Comparison of cutaneous tolerance and efficacy of calcitriol 3\u2003microg g(-1) ointment and tacrolimus 0.3\u2003mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial","volume":"157","author":"Liao","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000111510","article-title":"Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study","volume":"216","author":"Jacobi","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2133.2003.05228.x","article-title":"Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3\u2003microg g(-1) ointment and calcipotriol 50\u2003microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas","volume":"148","author":"Ortonne","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB19|cit19","first-page":"1461","article-title":"Treatment of psoriasis on the face with calcitriol ointment","volume":"43","author":"Jo","year":"2005","journal-title":"Korean J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/eje.0.1330007","article-title":"Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs","volume":"133","author":"Bouillon","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB21|cit21","first-page":"278","article-title":"Psoriasis treatment with vitamin D derivatives","volume":"11","author":"Menne","year":"1992","journal-title":"Semin Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2133.1996.d01-1075.x","article-title":"Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety","volume":"135","author":"Van De Kerkhof","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2133.1994.tb08458.x","article-title":"The effect of tacalcitol (1,24(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study","volume":"131","author":"Gerritsen","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB24|cit24","first-page":"166","article-title":"Tacalcitol ointment for psoriasis","volume":"186","author":"Nishimura","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1111\/j.1365-2133.2010.09758.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1034\/j.1600-0536.2000.042005260.x","article-title":"Placebo-controlled evaluation of the irritant potential of tacalcitol (1a,24-dihydroxyvitamin D3) in healthy volunteers","volume":"42","author":"Schlotmann","year":"2000","journal-title":"Contact Dermatitis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09758.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09758.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.09758.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:48:32Z","timestamp":1676382512000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/6\/1359\/6642848"}},"subtitle":["Tacalcitol in the treatment of facial psoriasis"],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09758.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,10]]}}}